Skip to main content
. 2013 Jan 14;14(1):1629–1654. doi: 10.3390/ijms14011629

Figure 1.

Figure 1

Uptake of albumin-paclitaxel nanoparticles is presumably mediated by the gp60 transcytosis pathway and subsequent binding to SPARC (Secreted Protein, Acidic and Richin Cysteine) in the tumor extracellular matrix. Reproduced with permission from Elsadek et al., Journal of Controlled Release; published by Elsevier, 2012.